Melanocortin Receptors as Targets in the Treatment of Obesity

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|7|11|1098-1110

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.7, Iss.11, 2007-06, pp. : 1098-1110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuropeptide Y receptors as targets of obesity treatment

By Ishihara PhD Akane   Moriya PhD Minoru   MacNeil PhD Douglas J   Fukami PhD Takehiro   Kanatani PhD Akio  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 12, 2006-12 ,pp. : 1701-1712

Informa Healthcare

Access to resources Recommend Favorite

Melanocortin Receptors as Drug Targets for Disorders of Energy Balance

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 3, 2006-06 ,pp. : 251-261

Bentham Science Publishers

Access to resources Recommend Favorite

Melanocortin - 4 Receptor Agonists for the Treatment of Obesity

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-06 ,pp. : 1121-1130

Bentham Science Publishers

Access to resources Recommend Favorite

Melanocortin peptides and their receptors: new targets for anti-inflammatory therapy

By Getting S.J.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 10, 2002-10 ,pp. : 447-449

Elsevier

Access to resources Recommend Favorite

Central G-Protein Coupled Receptors (GPCR)s as Molecular Targets for the Treatment of Obesity: Assets, Liabilities and Development Status

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 5, 2004-01 ,pp. : 357-377

Bentham Science Publishers

Access to resources Recommend Favorite